BONE CARE INTERNATIONAL LLC. V. ROXANE LABORATORIES INC. , No. 12-1525 (Fed. Cir. 2012)

Annotate this Case

Download PDF

Case: 12-1525 Document: 36 Page: 1 Filed: 11/07/2012 NOTE: This order is nonprecedential. Wniteb ~tate~ QCourt of ~peaI~ for tbe jfeberaI {[ircuit BONE CARE INTERNATIONAL LLC AND GENmME CORPORATION, Plaintiffs-Appellees, v. ROXANE LABORATORIES INC., Defendant-Appellant, AND SANDOZ INC., Defendant-Appellant, AND ANCHEN PHARMACEUTICALS INC., Defendant. 2012-1525, -1526 Appeals from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0285, Chief Judge Gregory M. Sleet. ON MOTION Case: 12-1525 Document: 36 Page: 2 Filed: 11/07/2012 BONE CARE INTERNATIONAL V. ROXANE LABORATORIES 2 ORDER Bone Care International LLC and Genzyme Corporation move without opposition for a 5-day extension of time, until November 6,2012, to file their response brief. Upon consideration thereof, IT Is ORDERED THAT: The motion is granted. FOR THE COURT /s/ Jan Horbaly Jan Horbaly Clerk s21

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.